Medtronic (MDT) Change in Receivables (2014 - 2026)

Medtronic's Change in Receivables history runs 13 years deep, the most recent figure standing at -$13.0 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 533.33% year-over-year to -$13.0 million; the TTM figure through Jan 2026 stood at $162.0 million (down 62.76% YoY), while the FY2025 annual figure was $433.0 million, up 10.74% from the prior year.
• Change in Receivables came in at -$13.0 million for Q1 2026 at Medtronic, down from $214.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $435.0 million in Q4 2022 to a low of -$288.0 million in Q3 2025.
• A 5-year average of $95.2 million and a median of $62.0 million in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables surged 232.06% in 2022 and tumbled 533.33% in 2026, its largest moves.
• Medtronic's Change in Receivables stood at $435.0 million in 2022, then sank by 35.4% to $281.0 million in 2023, then rose by 3.56% to $291.0 million in 2024, then retreated by 26.46% to $214.0 million in 2025, then slumped by 106.07% to -$13.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$13.0 million, $214.0 million, and -$288.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison